Satish K. Tadikonda
Senior Lecturer of Business Administration
Senior Lecturer of Business Administration
Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School. In the MBA program, Satish teaches The Entrepreneurial Manager, a required first-year MBA course, and Entrepreneurship in Life Sciences, an elective course for second-year MBA students. Prior to joining the faculty, he served as an Executive Fellow in Entrepreneurship and Entrepreneur-in-Residence at HBS over a period of six years, advising Harvard-based students and startups on all aspects of the entrepreneurial journey.
In addition to his faculty work, Satish is a serial entrepreneur in the life sciences and healthcare sectors. His main interests lie in Healthcare IT and at the intersection of drug, medical device and diagnostics development, and software systems development, primarily for accelerating clinical trials and regulatory approvals.
Satish’s current venture, Trove Health (mytrovehealth.com), focuses on building technology for the engagement and retention of patients in clinical trials. Prior to Trove Health, Satish founded a number of companies focused on developing technology products or services within life sciences R&D: Avigo Solutions (Managing Partner), Virtify (Founder and CEO), Tribiosys (Co-Founder) and Enmed (Co-Founder and CEO). Early in his career, Satish was the Director of the Imaging Lab at EPIX Medical, and also worked as a lead Engineer at Hewlett-Packard Medical Products Group, working on developing innovative MRI, Ultrasound, and Telemedicine products.
Additionally, Satish was also an active participant in helping develop drug and medical device industry standards. He has also published and presented several articles in peer-reviewed journals and international conferences on topics in cardiovascular and brain image analysis and other medical imaging technology topics.
Satish currently serves on the Board of Directors of Scripta Insights, ConnectM Technologies, Unruly Studios, Gradient Health and the non-profit Gateway for Cancer Research. He is also an Executive Advisor to Blue Cloud Ventures and Advisor to Two Lantern Ventures. Satish is a very active early-stage investor as a member of TiE Angels and TBD Angels, and serves on the advisory boards of a number of startups. He co-founded TiE ScaleUp, an accelerator focused on scaling seed and Series A companies, and mentors a number of entrepreneurs at TiE ScaleUp, MassChallenge, the Harvard iLab and the Rock Accelerator at HBS.
Satish holds a Doctorate in Electrical and Computer Engineering from the University of Iowa, and a Bachelor’s degree in Electrical and Electronics Engineering from Birla Institute of Technology and Science (Pilani).
Satish and his family live in Burlington, MA. They enjoy outdoor sports and are active members of their local community. Satish is an avid golfer and is a passionate college football fan, especially of the Hawkeyes.
- Cases and Teaching Materials
-
- Tadikonda, Satish, Olivia Reszczynski, and William Marks. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 825-071, August 2024. View Details
- Tadikonda, Satish, and William Marks. "Entrepreneurship in the Life Sciences Fall Term 2024: Course Outline and Syllabus." Harvard Business School Course Overview Note 825-009, August 2024. View Details
- Tadikonda, Satish, and William Marks. "Field Course: Life Sciences Venture Creation Fall Term 2024 - Course Outline and Syllabus." Harvard Business School Course Overview Note 825-010, August 2024. View Details
- Tadikonda, Satish, William Marks, and Amanda McEwen. "Intarcia: Regulatory Setbacks at a Unicorn (B)." Harvard Business School Case 824-112, June 2024. View Details
- Tadikonda, Satish, and William Marks. "Revvity: A Symbol of Change." Harvard Business School Case 824-071, October 2023. (Revised June 2024.) View Details
- Tadikonda, Satish, Amanda McEwen, Mansi Raythatha, and William Marks. "Intarcia: Regulatory Setbacks at a Unicorn (A)." Harvard Business School Case 824-050, September 2023. (Revised June 2024.) View Details
- Srinivasan, Suraj, Satish Tadikonda, Paul Dongha, Manoj Saxena, and Radhika Kak. "Managing AI Risks in Consumer Banking." Harvard Business School Case 124-093, April 2024. View Details
- Tadikonda, Satish, William Marks, Shardule Shah, and Calvin Marambo. "Gates Ventures: Making Alzheimer's a Forgotten Past." Harvard Business School Case 824-075, July 2024. View Details
- Tadikonda, Satish, and William Marks. "TetraScience: Unlocking the Power of Scientific Data." Harvard Business School Case 824-072, October 2023. (Revised April 2024.) View Details
- Tadikonda, Satish, and William Marks. "Veeva Systems: The Next Frontier." Harvard Business School Case 824-074, October 2023. (Revised April 2024.) View Details
- Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024. View Details
- Tadikonda, Satish, Jacqueline Grant, and William Marks. "Three Vignettes of Early Careers in the Life Sciences." Harvard Business School Case 824-054, August 2023. (Revised January 2024.) View Details
- Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.) View Details
- Tadikonda, Satish, William Marks, and Kevin Emancipator. "Thermo Fisher Scientific: Foray into Contract Research." Harvard Business School Case 824-073, October 2023. (Revised May 2024.) View Details
- Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023. View Details
- Tadikonda, Satish, William Marks, and Shardule Shah. "Alnylam: A Loud Silence (B)." Harvard Business School Supplement 824-042, October 2023. (Revised August 2024.) View Details
- Tadikonda, Satish, William Marks, and Shardule Shah. "Alnylam: A Loud Silence (A)." Harvard Business School Case 824-041, October 2023. (Revised July 2024.) View Details
- Tadikonda, Satish. "Atomwise: Strategic Opportunities in AI for Pharma." Harvard Business School Case 824-043, September 2023. (Revised April 2024.) View Details
- Tadikonda, Satish. "Creyon Bio: A VC's Investment Thesis." Harvard Business School Case 824-017, August 2023. View Details
- Tadikonda, Satish, William Marks, and Ananya Zutshi. "Jake Becraft and Strand Therapeutics: The Making of an Entrepreneur." Harvard Business School Case 824-046, August 2023. (Revised January 2024.) View Details
- Tadikonda, Satish, William Marks, and Kevin Emancipator. "Catalent: Catalyzing the Next Era of Growth." Harvard Business School Case 824-016, October 2023. (Revised June 2024.) View Details
- Tadikonda, Satish, and Sidhant Jena. "Augmenix: Space to Think Differently." Harvard Business School Case 824-031, August 2023. View Details
- Tadikonda, Satish, and Amanda McEwen. "Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations." Harvard Business School Case 824-018, August 2023. (Revised May 2024.) View Details
- Tadikonda, Satish, Shikhar Ghosh, and William Marks. "Moderna: Everything, Everywhere, All at Once." Harvard Business School Teaching Note 824-033, August 2023. View Details
- Tadikonda, Satish, and Ananya Zutshi. "Morphic Therapeutic: Making the Initial Pipeline Decisions." Harvard Business School Case 824-022, August 2023. (Revised May 2024.) View Details
- Tadikonda, Satish, Ananya Zutshi, Hunter Goble, and William Marks. "A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics." Harvard Business School Background Note 824-045, August 2023. View Details
- Tadikonda, Satish. "HealthVerity: Real World Data and Evidence." Harvard Business School Case 824-019, July 2023. View Details
- Tadikonda, Satish, Michael Singer, William Marks, and Wendi Yajnik. "Miracle Therapeutics: Negotiating an IP License (A)." Harvard Business School Case 824-020, July 2023. (Revised July 2024.) View Details
- Tadikonda, Satish, Shikhar Ghosh, and William Marks. "Moderna: Everything, Everywhere, All at Once." Harvard Business School Case 824-021, July 2023. View Details
- Weiss, Mitchell, Satish Tadikonda, Vincent Dessain, and Emer Moloney. "Nuritas." Harvard Business School Case 822-080, February 2022. (Revised November 2022.) View Details